To look at the occurrence of ipecac misuse in two high‐risk populations, we distributed a structured self‐report questionnaire regarding eating attitudes and behaviors to a non‐clinical sample of 5,537 young women in a national collegiate social organization and to a clinical sample of 299 consecutive outpatients referred to our Eating Disorders Clinic. The lifetime prevalence of ipecac use in the college population was 2.5% compared to 10% in the outpatient sample. The prevalence rates in both populations suggest that further restriction of syrup of ipecac by warnings of toxicity on labels, package inserts, and pharmacist dispensation over‐the‐counter should be considered.
|Number of pages
|International Journal of Eating Disorders
|Published - May 1992
ASJC Scopus subject areas
- Psychiatry and Mental health